~~<i id='AFB803786E'><strike id='AFB803786E'><tt id='AFB803786E'><pre id='AFB803786E'></pre></tt></strike></i>~~

Home» knowledge» leisure time

leisure time

author：knowledge 2025-09-28 18:13:24 Page View：77675

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart disease in astronauts blamed on cosmic radiation
Next article： What does generative AI mean for health care? We asked experts

focus

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

Seattle police shoot person suspected in downtown stabbing

SEATTLE--ASeattlepoliceofficershotapersononTuesdaywhowassuspectedofstabbinganotherpersondowntown,pol

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Resistance to cancer drugs: A new genetic explanation

MetastaticmelanomacellsNCI/NIHCancerdrugscanburnthroughtumorslikeawildfire,killingoffthevastmajority